Genomic News and Research

RSS
Caliper Life Sciences second-quarter GAAP revenue decreases 10% to $29.0 million

Caliper Life Sciences second-quarter GAAP revenue decreases 10% to $29.0 million

Scientists identify genetic basis for prostate cancer susceptibility in non-European population

Scientists identify genetic basis for prostate cancer susceptibility in non-European population

COGS receives $10 million renewal grant from National Institute of Mental Health

COGS receives $10 million renewal grant from National Institute of Mental Health

Genetics research team discovers new recurrent translocations

Genetics research team discovers new recurrent translocations

Researchers identify genetic mutation for Uner Tan Syndrome

Researchers identify genetic mutation for Uner Tan Syndrome

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

Positive results from study with Genome Sequencer FLX System for HIV drug-resistant mutation detection

Positive results from study with Genome Sequencer FLX System for HIV drug-resistant mutation detection

CvergenX acquires global rights to InterveneXRT technology for individualization of radiation therapy

CvergenX acquires global rights to InterveneXRT technology for individualization of radiation therapy

Affymetrix to develop, commercialize Axiom Chinese myDesign Genotyping Array

Affymetrix to develop, commercialize Axiom Chinese myDesign Genotyping Array

Affymetrix releases new data for rapid design of custom arrays

Affymetrix releases new data for rapid design of custom arrays

Control of cell migration gene can reduce spread of oral cancer cells: Study

Control of cell migration gene can reduce spread of oral cancer cells: Study

Study links application of disinfectants in recreational pools to adverse health outcomes

Study links application of disinfectants in recreational pools to adverse health outcomes

Affymetrix second-quarter total revenue decreases to $71.7 million

Affymetrix second-quarter total revenue decreases to $71.7 million

INRA Genomic Platform core facility now provides services on Fluidigm's BioMark System for Genetic Analysis

INRA Genomic Platform core facility now provides services on Fluidigm's BioMark System for Genetic Analysis

Affymetrix introduces Axiom Custom Genotyping Arrays

Affymetrix introduces Axiom Custom Genotyping Arrays

Scientists identify key genes for Silk Road disease

Scientists identify key genes for Silk Road disease

Meridian Bioscience completes acquisition of Bioline group of companies

Meridian Bioscience completes acquisition of Bioline group of companies

Quantitative capabilities of Helicos' single-molecule sequencing technology demonstrated

Quantitative capabilities of Helicos' single-molecule sequencing technology demonstrated

New approach to understand different cancer subtypes

New approach to understand different cancer subtypes

Jinfiniti Biosciences moves from clinical studies to developing biomarkers

Jinfiniti Biosciences moves from clinical studies to developing biomarkers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.